Stereotactic vacuum assisted breast biopsy has been developed as a minimally invasive alternative procedure to mammogram-guided wire localization then excision breast biopsy for non-palpable breast abnormalities.

OBJECTIVE: The aims of this study was to describe the Medical City experience on stereotactic vacuum assisted breast biopsy from September 2007 to December 2009.

METHODS: Review of patients' records, mammogram results and histopathology reports of all patients who had stereotactic breast biopsy done at the Medical City from September 2007 up to December 2009. Percentages of patients with BI-RADS category 4 on mammogram and of patients with positive histopathology results were calculated. Conclusions were obtained from the tally and the percentage computations. Present rates of stereotactic complications were noted as well.

RESULTS: There were 25 patients who had stereotactic vacuum assisted breast biopsy from September 2007 to December 2009. Of the 25 patients, 15 (60%) had mammogram results with BIRADS category 4. Of the 15 patients with BI-RADS category 4, 5(33.33%) had a histopathology diagnosis positive for malignancy.

CONCLUSION: Stereotactic vacuum assisted breast biopsy is more cost-effective as against mammogram-guided wire localization then excision breast biopsy with the present rates at our institution. Post stereotactic complications experiences by a few patients were very minor.

Human ; Vacuum ; Mammography ; Breast ; Breast Diseases ; Neoplasms